Circular RNA hsa_circ_0001649 suppresses the growth of osteosarcoma cells via sponging multiple miRNAs

References

• Gitelis S. Bone and soft tissue tumors: clinical features, imaging, pathology and treatment. JBJS. 2001;83:801–802.
   Google Scholar
• Kansara M, Teng MW, Smyth MJ, et al. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;14:722–735.
   PubMed Web of Science ®Google Scholar
• Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma. Curr Opin Pharmacol. 2014;16:15–23.
   PubMed Web of Science ®Google Scholar
• Luetke A, Meyers PA, Lewis I, et al. Osteosarcoma treatment – where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523–532.
   PubMed Web of Science ®Google Scholar
• Ouyang Z, Li H, Zhai Z, et al. Zoledronic acid: pleiotropic anti-tumor mechanism and therapeutic outlook for osteosarcoma. Curr Drug Targets. 2018;19:409–421.
   PubMed Web of Science ®Google Scholar
• Chan HS, Grogan TM, Haddad G, et al. P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy. J Natl Cancer Inst. 1997;89:1706–1715.
   PubMed Web of Science ®Google Scholar
• Sizemore G, Lucke-Wold B, Rosen C, et al. Temporal lobe epilepsy, stroke, and traumatic brain injury: mechanisms of hyperpolarized, depolarized, and flow-through ion channels utilized as tri-coordinate biomarkers of electrophysiologic dysfunction. OBM Neurobiol. 2018;2:009.
   PubMedGoogle Scholar
• Ivanov A, Memczak S, Wyler E, et al. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 2015;10:170–177.
   PubMed Web of Science ®Google Scholar
• Abu N, Jamal R. Circular RNAs as promising biomarkers: a mini-review. Front Physiol. 2016;7:355.
   PubMed Web of Science ®Google Scholar
• Salzman J. Circular RNA expression: its potential regulation and function. Trends Genet. 2016;32:309–316.
   PubMed Web of Science ®Google Scholar
• Wang P, He X. Current research on circular RNAs associated with colorectal cancer. Scand J Gastroenterol. 2017;52:1203–1210.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yao Y, Zhong X, et al. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells. Biochem Biophys Res Commun. 2018;496:455–461.
   PubMed Web of Science ®Google Scholar
• Ji W, Qiu C, Wang M, et al. Hsa_circ_0001649: a circular RNA and potential novel biomarker for colorectal cancer. Biochem Biophys Res Commun. 2018;497:122–126.
   PubMed Web of Science ®Google Scholar
• Zhang X, Qiu S, Luo P, et al. Down-regulation of hsa_circ_0001649 in hepatocellular carcinoma predicts a poor prognosis. Cancer Biomarkers. 2018;22:135–142.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384–388.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Bao C, Guo W, et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016;7:11215.
   PubMed Web of Science ®Google Scholar
• Qin M, Liu G, Huo X, et al. Hsa_circ_0001649: a circular RNA and potential novel biomarker for hepatocellular carcinoma. Cancer Biomarkers. 2016;16:161–169.
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng F, Xiao X, et al. CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Reports. 2017;18:1646–1659.
   Google Scholar
• Liu H, Liu Y, Bian Z, et al. Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 (Kip1) axis. Mol Cancer. 2018;17:151.
   PubMed Web of Science ®Google Scholar
• Quesnelle KM, Boehm AL, Grandis JR. STAT-mediated EGFR signaling in cancer. J Cell Biochem. 2007;102:311–319.
   PubMed Web of Science ®Google Scholar
• Roberts LE, Fini MA, Derkash N, et al. PD98059 enhanced insulin, cytokine, and growth factor activation of xanthine oxidoreductase in epithelial cells involves STAT3 and the glucocorticoid receptor. J Cell Biochem. 2007;101:1567–1587.
   PubMed Web of Science ®Google Scholar
• Linher-Melville K, Singh G. The complex roles of STAT3 and STAT5 in maintaining redox balance: lessons from STAT-mediated xCT expression in cancer cells. Mol Cell Endocrinol. 2017;451:40–52.
   PubMed Web of Science ®Google Scholar
• You X, Conrad TO. Acfs: accurate circRNA identification and quantification from RNA-Seq data. Sci Rep. 2016;6:38820.
   PubMed Web of Science ®Google Scholar
• Bolha L, Ravnik-Glavac M. Circular RNAs: biogenesis, function, and a role as possible cancer biomarkers. Int J Genom. 2017;2017:6218353.
   Google Scholar
• Chen BJ, Byrne FL, Takenaka K, et al. Analysis of the circular RNA transcriptome in endometrial cancer. Oncotarget. 2018;9:5786–5796.
   PubMedGoogle Scholar
• Lu C, Shi X, Wang AY, et al. RNA-Seq profiling of circular RNAs in human laryngeal squamous cell carcinomas. Mol Cancer. 2018;17:86.
   PubMed Web of Science ®Google Scholar
• Rothermundt C, Seddon BM, Dileo P, et al. Follow-up practices for high-grade extremity osteosarcoma. BMC Cancer. 2016;16:301.
   PubMed Web of Science ®Google Scholar
• Anderson ME. Update on survival in osteosarcoma. Orthop Clin North Am. 2016;47:283–292.
   PubMed Web of Science ®Google Scholar
• Peng N, Shi L, Zhang Q, et al. Microarray profiling of circular RNAs in human papillary thyroid carcinoma. PloS One. 2017;12:e0170287.
   PubMed Web of Science ®Google Scholar
• Qiu M, Xia W, Chen R, et al. The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma. Cancer Res. 2018;78:2839–2851.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu H, Hou L, et al. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol Cancer. 2017;16:151.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang J, Zou C, et al. Microarray expression profile and functional analysis of circular rnas in osteosarcoma. Cell Physiol Biochem. 2017;43:969–985.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sui X, Zhao H, et al. Decreased circular RNA hsa_circ_0001649 predicts unfavorable prognosis in glioma and exerts oncogenic properties in vitro and in vivo. Gene. 2018;676:117–122.
   PubMed Web of Science ®Google Scholar
• Kulcheski FR, Christoff AP, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016;238:42–51.
   PubMed Web of Science ®Google Scholar
• Li F, Zhang L, Li W, et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/beta-catenin pathway. Oncotarget. 2015;6:6001–6013.
   PubMed Web of Science ®Google Scholar
• Long J, Luo J, Yin X. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82. Biomed Pharmacothe. 2018;102:1195–1202.
   PubMed Web of Science ®Google Scholar
• Liu S, Qu D, Li W, et al. miR647 and miR1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer. Mol Med Rep. 2017;16:8189–8199.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang Z, Sun J, et al. MiR-942 regulates the function of breast cancer cell by targeting FOXA2. Biosci Rep. 2019;39. DOI:https://doi.org/10.1042/BSR20192298.
   Google Scholar
• Lei D, Zhang F, Yao D, et al. MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1. Biomed Pharmacothe. 2017;89:957–965.
   PubMed Web of Science ®Google Scholar
• Qin K, Tian G, Chen G, et al. miR-647 inhibits glioma cell proliferation, colony formation, and invasion by regulating HOXA9. J Gene Med. 2019. p. e3153.
   Google Scholar
• Mendrzyk F, Radlwimmer B, Joos S, et al. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. J Clin Oncol. 2005;23:8853–8862.
   PubMed Web of Science ®Google Scholar
• Koontongkaew S, Chareonkitkajorn L, Chanvitan A, et al. Alterations of p53, pRb, cyclin D(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas. Oral Oncol. 2000;36:334–339.
   PubMed Web of Science ®Google Scholar
• Poomsawat S, Buajeeb W, Khovidhunkit SO, et al. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. J Oral Pathol Med. 2010;39:793–799.
   PubMed Web of Science ®Google Scholar
• Zhu K, Liu L, Zhang J, et al. MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6. Protein Cell. 2016;7:434–444.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhao L, Wang Q. Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/beta-catenin pathway. Am J Transl Res. 2016;8:2385–2393.
   PubMed Web of Science ®Google Scholar
• Nam S, Xie J, Perkins A, et al. Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells. Mol Oncol. 2012;6:484–493.
   PubMed Web of Science ®Google Scholar
• Wei R, Yang Q, Han B, et al. microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways. Oncotarget. 2017;8:16633–16641.
   PubMedGoogle Scholar
• Yang N, Han F, Cui H, et al. Matrine suppresses proliferation and induces apoptosis in human cholangiocarcinoma cells through suppression of JAK2/STAT3 signaling. Pharmacol Rep. 2015;67:388–393.
   PubMed Web of Science ®Google Scholar
• Hu H, Wang S, Shi D, et al. Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathway. Onco Targets Ther. 2019;12:5377–5388.
   PubMed Web of Science ®Google Scholar
• Yun HM, Park KR, Quang TH, et al. 4-parvifuran inhibits metastatic and invasive actions through the JAK2/STAT3 pathway in osteosarcoma cells. Arch Pharm Res. 2017;40:601–609.
   PubMed Web of Science ®Google Scholar
• Wang J, Ni J, Yi S, et al. Protein inhibitor of activated STAT xalpha depresses cyclin D and cyclin D kinase, and contributes to the inhibition of osteosarcoma cell progression. Mol Med Rep. 2016;13:1645–1652.
   PubMed Web of Science ®Google Scholar
• Angulo P, Kaushik G, Subramaniam D, et al. Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy. J Hematol Oncol. 2017;10:10.
   PubMed Web of Science ®Google Scholar